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We have investigated the genetic basis of gastric carcino-
mas occurring in patients aged under 40 years from a
Portuguese population with a relatively high incidence of
gastric cancer. We analysed a panel of 12 microsatellite loci in
DNA extracted from gastric carcinomas arising in 16 patients
aged 24–39 years from Braga, Portugal. Overall, microsatel-
lite instability (MI) in at least 1 locus was detected in 44% (7 of
16) of carcinomas. A single patient demonstrated a mutator
phenotype suggestive of the hereditary nonpolyposis colorec-
tal cancer syndrome with instability in 82% of loci. This
carcinoma showed loss of expression of the hMLH1 mismatch
repair protein. In a previous study, we found no evidence of
MI among 10 cases of early onset gastric carcinomas from an
English population, which has a relatively low incidence of
gastric cancer. Comparing the 2 series, we found that there
was a significant difference (p 5 0.04) in the prevalence of MI
(at least 1 marker affected). This geographical difference in
low-level MI may be related to a significantly higher preva-
lence of background chronic atrophic gastritis (8 of 16 vs. 0 of
8) and Helicobacter pylori infection (15 of 16 vs. 2 of 8) in
Portuguese carcinomas compared with English cases. Ge-
netic mechanisms underlying the hereditary non-polyposis
colorectal cancer syndrome may play a role in a small
number of early onset gastric carcinomas. The difference in
prevalence of low-level MI between these relatively high and
low incidence European populations requires further investi-
gation. Int. J. Cancer 85:189–191, 2000.
r 2000 Wiley-Liss, Inc.
In general, Western populations have a relatively low incidence
of gastric cancer but there are some Western countries, such as
Portugal and Finland, where the incidence of gastric cancer is
relatively high (Neugut et al., 1996). The genetic mechanisms
responsible for these geographical differences are unexplored.
Early onset gastric carcinomas (i.e., arising in patients aged under
40 years) are usually diffuse, infiltrating, poorly differentiated and
may be associated with poor prognosis (Mecklin et al., 1988).
Patients with early onset gastric carcinomas are uncommon and
may have a hereditary aetiology such as a germline E-cadherin
mutation or hereditary non-polyposis colorectal cancer (HNPCC;
Vasen et al., 1990; Guilford et al., 1998).
HNPCC families are characterised by the early onset and a high
frequency of colorectal, gastric and endometrial carcinoma when
compared with the normal population. Carcinoma DNA obtained
from HNPCC patients shows widespread microsatellite instability
(MI) when compared with ‘‘normal’’ constitutional DNA from the
same person (Aaltonen et al., 1993; Peltomaki et al., 1993). This
replication error (RER) positive phenotype arises in the majority of
cases due to mutation in the DNA mismatch repair genes hMSH2 or
hMLH1 (Peltomaki and Vasen, 1997). An RER-positive phenotype
has been detected in 47% of gastric carcinomas obtained from
HNPCC families in Finland (Aarnio et al., 1997). A small
proportion of ‘‘sporadic’’ colorectal, gastric and endometrial carci-
nomas also demonstrate an RER-positive phenotype (Peltomaki et
al., 1993).
We aimed to compare the frequency of MI in early onset gastric
carcinomas from European patients residing in areas of high
(Braga, Portugal) and low (Yorkshire, UK) gastric cancer inci-
dence. The frequency of RER positivity in the Braga patients may
indicate whether HNPCC could account for the increased gastric
cancer incidence in the area, possibly due to a founder mutation
effect as seen in Finland (Papadopoulos et al., 1994). We have
previously investigated 10 gastric carcinomas arising in patients
under the age of 40 from Yorkshire and found no evidence of MI
(Hayden et al., 1997b). We have used identical methods to
investigate 16 patients aged under 40 years with gastric carcinoma
from Braga, a region of Portugal with a relatively high incidence of
gastric cancer, to determine whether there is a variation in the
prevalence of RER positivity which may explain the geographical
difference in incidence.
MATERIAL AND METHODS
Details of the patients
Paraffin-embedded tissue from 16 young gastric carcinoma
patients was obtained from the Hospital de Sao Marco, Braga,
Portugal. There were 10 male and 6 female patients aged 24–39
years at the time of diagnosis (median of 34 years). Carcinomas
were located in the middle (n 5 5) and distal third (n 5 11) of the
stomach (Table I). The cases were examined by an experienced
gastrointestinal pathologist, as in Hayden et al. (1997b). The
degree of differentiation was assessed (Watanabe et al., 1990) and
the histological appearances were categorised according to the
classifications of Lauren (1965), Ming (1977), and Goseki et al.
(1992). Tumour stage was assessed in accordance with the TNM
classification system. The histological features of the ‘‘back-
ground’’ gastric mucosa and presence of Helicobacter pylori
(modified Giemsa stain) were also recorded (Table I).
DNA extraction
Separate areas containing normal gastric mucosa or smooth
muscle and corresponding gastric carcinoma (comprising at least
50% neoplastic cells) were outlined on a representative haematoxy-
lin and eosin-stained section. Selected areas of tissue were micro-
dissected from consecutive formalin-fixed sections and DNA was
extracted using a standard phenol/chloroform method (Hayden et
al., 1997b).
Fluorescent PCR and detection of MI
Fluorescent PCR was performed using a panel of 12 microsatel-
lite markers as previously described, for 30–40 cycles of amplifica-
tion under optimised reaction conditions (Hayden et al., 1997b).
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The microsatellites used were: D2S123, D3S966, D3S1076, D5S82,
D5S346 (DP1), D10S197, D11S904, D13S175, BAT25, NM23,
p53 and DCC (Aaltonen et al., 1993; Cawkwell et al., 1994; Jones
et al., 1992; Liu et al., 1995; Spirio et al., 1993). All consisted of
dinucleotide repeat motifs except BAT25 (mononucleotide) and
p53 (pentanucleotide). PCR products were electrophoresed on a
6% polyacrylamide gel using an automated DNA sequencer model
373A (Applied Biosystems, Foster City, CA) and MI visualised
using Genescan Analysis software (Applied Biosystems). MI was
recorded when 1 or more additional peaks occurred in the
carcinoma DNA sample which were absent from normal DNA
from the same patient (Cawkwell et al., 1995). Results were
obtained for a minimum of 4 markers per sample.
Immunohistochemical staining for hMSH2 and hMLH1
Immunohistochemical staining for mismatch repair proteins was
performed using monoclonal antibodies against hMSH2 (NA27,
Calbiochem, Nottingham, UK) and hMLH1 (13291A, Phar-
Mingen, San Diego, CA) as previously described (Cawkwell et al.,
1999). Immunohistochemical results were scored blind from the
MI results for each case. Loss of expression was scored whenever
staining was absent from tumour cells but present in adjacent
non-neoplastic tissue.
Statistical analysis
All p values were calculated using Chi square with Yate’s
correction.
RESULTS
Each case was analysed with 12 microsatellite markers. Results
were obtained for a minimum of 4, and an average of 7, loci per
case. The overall frequency of MI in at least 1 locus was 44% (7 of
16) of carcinomas (Table I). Six cases (38%) showed low-level MI
(only 1 marker affected). A single patient (6%) demonstrated a
mutator phenotype suggestive of the HNPCC syndrome with
instability in 82% of loci. This carcinoma exhibited normal hMSH2
expression but loss of expression of the hMLH1 protein when
compared with adjacent normal mucosa, which stained positively
with both antibodies.
The MI results were compared with our previous study of early
onset gastric carcinomas from Yorkshire (Hayden et al., 1997b). In
this study, results were obtained for a minimum of 5, and an
average of 9, loci per case. There was a significant difference in the
prevalence of MI (at least 1 marker affected) between the patients
from Braga and Yorkshire (6 of 16 vs. 0 of 10, p 5 0.04). The
assessment of background mucosa revealed a significantly higher
incidence of H. pylori infection (15 of 16 vs. 2 of 8; p 5 0.002) and
chronic atrophic gastritis (8 of 16 vs. 0 of 8; p 5 0.04) in the Braga
cases. Of the 6 Braga cases which exhibited low-level MI, 4 had
chronic atrophic gastritis and H. pylori infection. There were no
significant differences in the prevalence of the remaining clinico-
pathological features between the 2 groups.
DISCUSSION
The diagnosis of gastric carcinoma in patients under the age of
40 is a rarity in most European populations and is uncommon even
in countries or regions with a relatively high incidence. Thus, of
necessity, this study is based on a small number of cases.
Using a fluorescent PCR technique, we have found that 44% of
early onset gastric carcinomas arising in patients from the Braga
region of Portugal showed evidence of MI. An RER-positive
phenotype, with associated defective hMLH1 expression, was
detected in 1 female patient aged 38 years who had a 65 year-old
first degree relative affected by gastric carcinoma. This patient may
have a germline HNPCC mutation or, alternatively, the mismatch
repair system may have been inactivated in the tumour by
hypermethylation of the hMLH1 promoter (Leung et al., 1999).
None of the remaining patients had a family history of an
HNPCC-associated carcinoma. Our results suggest that HNPCC
may play a role in a small number of young patients with gastric
carcinoma from high incidence European populations.
There have been contrasting reports concerning the prevalence
of the RER-positive phenotype in gastric carcinomas from older
patients from different populations. Studies of high incidence
populations have reported RER positivity in 22–33% of cases
(Chung et al., 1996; Semba et al., 1996). In contrast, series from
low incidence countries have revealed a prevalence of 4–9%
(Keller et al., 1995; Hayden et al., 1997a). Among young patients
from both high and low incidence populations, we have found a
paucity of RER-positive cases. This is less surprising since we and
others (Keller et al., 1995; Chung et al., 1996; Hayden et al.,
1997a) have shown that RER-positive gastric carcinomas tend to
be of the intestinal subtype, rather than diffuse. Therefore, a low
prevalence of RER-positive cases may be expected in series
comprising predominantly diffuse-type gastric carcinomas.
Although the number of cases in both series is low, we found a
significant difference in the prevalence of MI, particularly at a low
TABLE I – CHARACTERISTICS OF PORTUGUESE EARLY ONSET GASTRIC CARCINOMAS
Case number Sex, age (years) FH1 Location Stage2 Lauren Ming Goseki Grade3 Mucosa4 HP5 MI (%)6
1 M, 24 No Antrum I* Intestinal Infiltrating IV PD CG, IM No 0/8 (0)
2 M, 26 No Body I Diffuse Infiltrating IV PD CAG, IM Yes 1/5 (20)
3 M, 28 No Antrum III Diffuse Infiltrating IV PD CG Yes 0/11 (0)
4 M, 29 No Antrum III Diffuse Infiltrating IV PD CG Yes 1/6 (17)
5 M, 30 No Body IV Diffuse Infiltrating IV PD CAG Yes 1/6 (14)
6 F, 30 No Antrum I* Diffuse Infiltrating IV PD CAG, IM Yes 0/6 (0)
7 F, 31 No Antrum II Diffuse Infiltrating IV PD CG, IM Yes 1/10 (10)
8 M, 34 No Antrum I* Diffuse Infiltrating IV PD CAG Yes 1/4 (25)
9 M, 34 No Body III Diffuse Infiltrating IV PD CAG Yes 0/6 (0)
10 M, 35 No Antrum I* Diffuse Infiltrating IV PD CG Yes 0/5 (0)
11 F, 37 No Antrum III Diffuse Infiltrating IV PD CG Yes 0/7 (0)
12 F, 37 No Body III Diffuse Infiltrating IV PD CAG, IM Yes 0/8 (0)
13 F, 38 Yes Antrum I Diffuse Expansile III PD CG, IM Yes 9/11 (82)
14 M, 38 No Body III Mixed Infiltrating IV PD CAG, IM Yes 1/8 (13)
15 M, 39 No Antrum II Intestinal Infiltrating I MD CAG, IM Yes 0/10 (0)
16 M, 39 No Antrum II Diffuse Infiltrating IV PD CG Yes 0/6 (0)
1FH: family history of HNPCC-associated neoplasms.–2UICC classification (*carcinoma confined to the mucosa or submucosa).–3WHO
classification: MD, moderately differentiated; PD, poorly differentiated.–4Background gastric mucosa. CG, chronic gastritis; CAG, chronic
gastritis with atrophy; IM, multifocal intestinal metaplasia.–5H pylori identified.–6MI (%): number of MI-positive loci/number of markers yielding
results (%).
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level, between early onset English and Portuguese gastric carcino-
mas. This has not previously been reported and may warrant further
investigation. Variation in the prevalence of low-level MI could be
attributable to the significant difference in the level of background
chronic atrophic gastritis which was observed. MI has been found
in chronic pancreatitis (Brentnall et al., 1995), ulcerative colitis
(Brentnall et al., 1996) and in intestinal metaplasia adjacent to
gastric carcinomas (Semba et al., 1996). It has been suggested that
continuous cell regeneration in chronic inflammatory conditions
may lead to saturation of the mismatch repair system, leading to
uncorrected errors detected as MI (Brentnall et al., 1996). It is
known that H. pylori infection causes chronic atrophic gastritis
(Correa and Shiao, 1994), inflicts oxidative DNA damage on gastric
mucosa (Baik et al., 1996) and has been linked with the development of
gastric carcinoma (Forman et al., 1993). Infection with this organism
occurs at a high frequency among young patients from high incidence
populations (Forman et al., 1993) and this was found to be the case in
the Portuguese series presented here. Chronic inflammation caused by
H. pylori could result in the saturation of DNA repair mechanisms
and conceivably lead to the development of low-level MI. The
possibility that other environmental agents could give rise to this
genetic abnormality requires further investigation.
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